Literature DB >> 9331798

Phagocytic, serological, and protective properties of streptococcal group A carbohydrate antibodies.

J B Zabriskie1, T Poon-King, M S Blake, F Michon, M Yoshinaga.   

Abstract

Group A streptococcal antibodies promote phagocytosis of several different strains of GR A streptococci. These antibodies passively protect against an in vivo mouse challenge model.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9331798     DOI： 10.1007/978-1-4899-1825-3_214

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


  8 in total

1.  Vaccination against rheumatic heart disease: a review of current research strategies and challenges.

Authors:  Manisha Pandey; Michael R Batzloff; Michael F Good
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

Review 2.  Strategies in the development of vaccines to prevent infections with group A streptococcus.

Authors:  Michael F Good; Michael R Batzloff; Manisha Pandey
Journal:  Hum Vaccin Immunother       Date:  2013-06-28       Impact factor: 3.452

Review 3.  Advances in potential M-protein peptide-based vaccines for preventing rheumatic fever and rheumatic heart disease.

Authors:  Michael R Batzloff; Manisha Pandey; Colleen Olive; Michael F Good
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

4.  Active and passive intranasal immunizations with streptococcal surface protein C5a peptidase prevent infection of murine nasal mucosa-associated lymphoid tissue, a functional homologue of human tonsils.

Authors:  Hae-Sun Park; P Patrick Cleary
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

5.  Doubly branched hexasaccharide epitope on the cell wall polysaccharide of group A streptococci recognized by human and rabbit antisera.

Authors:  Francis Michon; Samuel L Moore; John Kim; Milan S Blake; France-Isabelle Auzanneau; Blair D Johnston; Margaret A Johnson; B Mario Pinto
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

Review 6.  Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections.

Authors:  Michael S Bronze; James B Dale
Journal:  Am J Med Sci       Date:  2010-09       Impact factor: 2.378

7.  Active and passive immunizations with the streptococcal esterase Sse protect mice against subcutaneous infection with group A streptococci.

Authors:  Mengyao Liu; Hui Zhu; Jinlian Zhang; Benfang Lei
Journal:  Infect Immun       Date:  2007-05-14       Impact factor: 3.441

8.  Immunotherapy targeting the Streptococcus pyogenes M protein or streptolysin O to treat or prevent influenza A superinfection.

Authors:  Andrea L Herrera; Christopher Van Hove; Mary Hanson; James B Dale; Rodney K Tweten; Victor C Huber; Diego Diel; Michael S Chaussee
Journal:  PLoS One       Date:  2020-06-23       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.